Connect
About
Diego Civitelli is a Senior Researcher at the Medical Technology Research Group, where he leads policy research on innovative commercial agreements for medicines access in the NHS.
His current work centres on the evaluation of England's first Population Health Agreement, engaging directly with senior national and local NHS stakeholders to shape the UK policy discourse on future medicines access deals. He also conducts comparative policy analysis of innovative commercial agreements across European health systems.
Previously, as Research Associate at LSE Health, Diego co-led a project building the policy and economic case for patient engagement in clinical trials and monitored HTA agency practices across multiple jurisdictions, with a focus on real-world evidence. He has also contributed to research at LSE's Care Policy and Evaluation Centre on informal caregiving determinants and projections of learning disability prevalence and care needs in England.
Before joining LSE Health full-time, Diego worked as an Analyst at a market access consultancy, a healthcare consultancy, where he monitored the pricing and reimbursement landscape across European markets and developed policy materials to support pharmaceutical affiliate engagement with national policymakers.
Diego's research has been published in Pharmacoepidemiology and Drug Safety, and he has presented at multiple ISPOR conferences, including work on life-years lost due to regulatory and reimbursement delays and the value of patient engagement in clinical development. He has several working papers on population health agreements, access delays, and risk-adjusted valuation of patient engagement in clinical trials.
Diego holds an MSc in International Health Policy (Health Economics) from LSE, awarded with Distinction, and a First-Class BSc in Economics from the University of Leeds.
Expertise
Health economics, Econometrics, Health Technology Assessment